0 Items
Select Page

Toxoplasma gondii

Toxoplasma gondii (T. gondii) causes the parasitic disease Toxoplasmosis. It is a widespread disease that primarily affects members of the cat family but can be transmitted to humans through infected meat and cat faeces. Most humans infected with T.gondii remain asymptomatic or develop mild flu-like symptoms but severe clinical disease can occur in immunocompromised patients. In addition, T. gondii infection in pregnant women can cause congenital defects in the newborn or may lead to spontaneous abortion.

The Native Antigen Company offer high quality reagents for T.gondii research and immunoassay development.

Toxoplasma gondii Background

Toxoplasma gondii (T. gondii) is an obligate intracellular parasitic protozoan of the phylum Apicomplexa. It is the causative agent of the disease Toxoplasmosis, a common parasitic zoonoses which is widespread throughout most of the world. The domestic cat and other members of the family Felidae are the only definitive hosts for T.gondii. However, T.gondii is also capable of infecting a wide range of birds and mammals, including humans, which act as intermediate hosts.

In domestic cats, sexual replication of T.gondii occurs with the release of oocysts, in cat faeces, into the environment. In humans, T.gondii is primarily acquired by ingesting undercooked meat contaminated with bradyzoites (tissue cysts), drinking water contaminated by oocysts, or via accidental ingestion of cat faeces containing oocysts. In pregnant women, infected with T.gondii, vertical transmission of the parasite can occur causing congenital defects or miscarriage. In addition, infection via blood transfusion and organ transplant can also occur in rare cases (CDC).

In humans, ingestion of T.gondii tissue cysts or oocysts causes rupture of the cyst wall releasing sporozoites, which invade enterocytes in the small intestine and start to replicate. Infected cells then release tachyzoites which can enter adjacent cells and continue to multiply. This process of cell invasion and intracellular replication can continue allowing tachyzoites to disseminate throughout the body affecting multiple organs. After initial infection, tachyzoites form bradyzoites in human nerve and muscle tissue where T.gondii can remain dormant during the life of the host (Black, MW).

Most humans infected with T.gondii remain asymptomatic, or may present with mild flu-like symptoms including fever, headache, muscle pain and lymphadenopathy. However, in immunocompromised individuals, Toxoplasmosis can cause clinical disease including retinochoroiditis, myocarditis and meningoencephalitis, potentially leading to death. In pregnant women, T.gondii infection during the early stages of pregnancy can result in a miscarriage, a stillborn baby or congenital defects of the newborn including visual defects and mental disability (CDC).

Diagnosis of T.gondii infection is currently perfomed using serological techniques and indirect immunofluorescence to detect Toxoplasma specific antibodies.

References

Centers for Disease Control and Prevention: Parasites – Toxoplasmosis (Toxoplasma infection)

Black MW, Boothroyd JC. 2000. Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev. Sep;64(3):607-23.

Toxoplasma gondii Antigens – Coming soon!

We offer a panel of T. gondii antigens suitable for the development of ELISA and other immunoassays.

Toxoplasma gondii Antibodies

We offer a monoclonal antibody specific to T. gondii, suitable for the development of ELISA and other immunoassays.

Questions?

Check out our FAQ section for answers to the most frequently asked questions about our website and company.

A Q&A with David Flavell of Leukaemia Busters

In this blog, we speak with Dr. David Flavell about his scientific career, the legacy of Leukaemia Busters, and the recent impact that COVID-19 has had on his research.Tell me about your scientific background David. I was born in a seaside town called Southport in...

Avoiding the Immunopathology Pitfalls of a COVID-19 Vaccine

In the second of a three-part series on COVID-19 vaccines, we explore the potential challenges in stimulating safe vaccine responses and outline the role that diagnostics will play in guiding their development.Rogue Responses Antibodies play a crucial role in...

The Bumpy Road to a Cytomegalovirus Vaccine

The development of a cytomegalovirus vaccine has been 50 years in the making. Are there any technologies in the pipeline that could prompt a breakthrough? This article was originally posted online at The Medicine Maker, a Texere publication.To say that...

Why We Need Antigen and Antibody Tests for COVID-19

RT-PCR is the workhorse of viral diagnosis and has been invaluable in COVID-19 case confirmation and isolation guidance. However, while fast and sensitive, PCR suffers from some inherent drawbacks that limit it to diagnosis during the acute phase of infection. To...

Gonorrhea: What’s Currently in the Clinical Pipeline?

This article was written by our friends at Infectious Diseases Hub, a free-to-access website that aims to deliver up-to-date, essential research and information on all aspects of microbiology, virology, mycology and parasitology – from bench to bedside....

Get in Touch

We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these

5 + 10 =

Live Customer Feedback

Join our mailing list

* indicates required